当前位置: 首页 > 期刊 > 《糖尿病新世界》 > 2017年第19期
编号:13253135
西格列汀联合门冬及地特胰岛素对2型糖尿病患者血糖波动影响的研究(3)
http://www.100md.com 2017年10月1日 《糖尿病新世界》 2017年第19期
     綜上所述,该研究中给予患者西格列汀联合门冬及地特胰岛素方案降糖,可减少血糖波动,为指导临床用药提供更多证据。

    [参考文献]

    [1] 王汝龙,母义明,胡欣. 2型糖尿病治疗的新选择——DPP-4抑制剂[J]. 中国药学杂志,2014(8):702-704.

    [2] Takahara M, Shiraiwa T, Kaneto H, et al. Efficacy of sitag liptin on blood glucose fluctuation in Japanese type 2 diabetic patients with basal-supported oral therapy[J]. Endocrine journal, 2012,59(12):1131-1136.

    [3] Mori Y, Taniguchi Y, Matsuura K, et al. Effects of sitagliptin on 24-h glycemic changes in Japanese patients with type 2 diabetes assessed using continuous glucose monitoring[J]. Diabetes technology & therapeutics, 2011, 13(7): 699-703.

    [4] Tajiri Y, Kawano S, Hirao S, et al. Adding of Sitagliptin on Insulin Therapy Effectively and Safely Reduces a Hemoglobin A1c Level and Glucose Fluctuation in Japanese Patients with Type 2 Diabetes[J]. International Scholarly Research Notices, 2014.

    [5] Mori Y, Taniguchi Y, Miyazaki S, et al. Effects of add-on treatment with sitagliptin on narrowing the range of glucose fluctuations in Japanese type 2 diabetes patients receiving insulin therapy[J]. Diabetes technology & therapeutics, 2013, 15(3): 237-240.

    (收稿日期:2017-07-11), 百拇医药(陈俊 齐昊)
上一页1 2 3